| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 394730-60-0 | Boceprevir(EBP-520 SCH-503034) |
≥98% | | 询价 |
| 2 | 1009119-65-6 | Daclatasvir dihydrochloride |
≥98% | | 询价 |
| 3 | 1241946-89-3 | Simeprevir sodium |
≥98% | | 询价 |
| 4 | 923604-59-5 | Simeprevir |
≥98% | | 询价 |
| 5 | 630420-16-5 | Asunaprevir |
≥98% | | 询价 |
| 6 | 34240-05-6 | Adenosine Dialdehyde(ADOX) |
≥98% | | 询价 |
| 7 | 1338545-07-5 | OTS964 HCl |
≥98% | | 询价 |
| 8 | 1338540-63-8 | OTS514 |
≥98% | | 询价 |
| 9 | 1446090-79-4 | Lifirafenib(BGB-283) |
≥98% | | 询价 |
| 10 | 1951483-29-6 | Temuterkib(LY3214996) |
≥98% | | 询价 |
| 11 | 1781834-93-2 | FIPI HCl |
≥98% | | 询价 |
| 12 | 1431866-33-9 | WEHI-539 |
≥98% | | 询价 |
| 13 | 1223001-53-3 | STK16-IN-1 |
≥98% | | 询价 |
| 14 | 143360-00-3 | SMIP004 |
≥98% | | 询价 |
| 15 | 271576-80-8 | SD-06 |
≥98% | | 询价 |
| 16 | 874101-00-5 | RO4987655 |
≥98% | | 询价 |
| 17 | 1334719-95-7 | Q203(IAP6) |
≥98% | | 询价 |
| 18 | 152121-53-4 | PD 169316 |
≥98% | | 询价 |
| 19 | 1377239-83-2 | PBTZ169 |
≥98% | | 询价 |
| 20 | 269718-83-4 | Pardoprunox HCI |
≥98% | | 询价 |
| 21 | 1123231-07-1 | WAY-262611 |
≥98% | | 询价 |
| 22 | 312271-03-7 | M2I-1 |
≥98% | | 询价 |
| 23 | 344897-95-6 | Leukadherin-1 |
≥98% | | 询价 |
| 24 | 774549-97-2 | KM 11060 |
≥98% | | 询价 |
| 25 | 1428729-56-9 | KIN1148 |
≥98% | | 询价 |
| 26 | 1392116-14-1 | JD5037 |
≥98% | | 询价 |
| 27 | 937263-43-9 | Irbinitinib |
≥98% | | 询价 |
| 28 | 331001-62-8 | IQ-1 |
≥98% | | 询价 |
| 29 | 36945-98-9 | Icilin |
≥98% | | 询价 |
| 30 | 1640282-31-0 | I-CBP112 |
≥98% | | 询价 |
| 31 | 313254-51-2 | ICA-121431 |
≥98% | | 询价 |
| 32 | 95167-41-2 | DY131 |
≥98% | | 询价 |
| 33 | 1365888-06-7 | Brilanestrant |
≥98% | | 询价 |
| 34 | 15301-69-6 | Flavoxate |
≥98% | | 询价 |
| 35 | 863774-58-7 | Dimethylenastron |
≥98% | | 询价 |
| 36 | 1564286-55-0 | CWHM-12 |
≥98% | | 询价 |
| 37 | 37333-48-5 | Coenzyme F420-1(Factor F420-1) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 38 | 1174-92-1 | Cholesteryl methyl ether |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 39 | 149301-79-1 | Arachidonyl trifluoromethyl ketone |
≥98% | | 询价 |
| 40 | 10179-57-4 | MLS-573151 |
≥98% | | 询价 |
| 41 | 191231-97-7 | XC-DAPOL-CPBA |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 42 | 40951-21-1 | α-Hydroxyglutaric Acid(sodium salt) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 43 | 362045-44-1 | Etimicin Sulphate |
≥98% | | 询价 |
| 44 | 152571-61-4 | BSTFA-TMCS |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 45 | 1098-92-6 | Kaempferol 5,7,4'-trimethyl ethe |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 46 | 682745-40-0 | Tivozanib hydrate |
≥98% | | 询价 |
| 47 | 67037-37-0 | Eflornithine |
≥98% | | 询价 |
| 48 | 828934-40-3 | S-(+)-Etomoxir |
≥98% | | 询价 |
| 49 | 132308-39-5 | R-(+)-Etomoxir Potassium |
≥98% | | 询价 |
| 50 | 618109-05-0 | Voriconazole N-oxide |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 51 | 123642-27-3 | MDL 73811 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 52 | 1422365-93-2 | IM156 |
≥98% | | 询价 |
| 53 | 1258457-59-8 | TLR7/8 agonist 1 HCl |
≥98% | | 询价 |
| 54 | 444197-71-1 | BMS 249798 |
≥98% | | 询价 |
| 55 | 1258457-59-8 | TLR7/8 agonist 1 |
≥98% | | 询价 |
| 56 | 1707-75-1 | TEPA |
≥98% | | 询价 |
| 57 | 57672-79-4 | Baccatin VI |
≥98% | | 询价 |
| 58 | 1799330-15-6 | LXE408 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 59 | 936112-69-5 | GSK3 Inhibitor XV |
≥98% | | 询价 |
| 60 | 61318-90-9 | Sulconazole(RS44872) |
≥98% | | 询价 |
m.cnreagent.com